290 related articles for article (PubMed ID: 10604642)
1. Hemolytic uremic syndrome: defining the need for long-term follow-up.
Small G; Watson AR; Evans JH; Gallagher J
Clin Nephrol; 1999 Dec; 52(6):352-6. PubMed ID: 10604642
[TBL] [Abstract][Full Text] [Related]
2. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update.
Garg AX; Salvadori M; Okell JM; Thiessen-Philbrook HR; Suri RS; Filler G; Moist L; Matsell D; Clark WF
Am J Kidney Dis; 2008 Mar; 51(3):435-44. PubMed ID: 18295059
[TBL] [Abstract][Full Text] [Related]
3. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
[TBL] [Abstract][Full Text] [Related]
4. Long-term (15-25 years) outcome of childhood hemolytic-uremic syndrome.
Gagnadoux MF; Habib R; Gubler MC; Bacri JL; Broyer M
Clin Nephrol; 1996 Jul; 46(1):39-41. PubMed ID: 8832149
[TBL] [Abstract][Full Text] [Related]
5. [Hemolytic uremic syndrome: long term renal injury].
Lumbreras Fernández J; Cruz Rojo J; Iñigo Martín G; Muley Alonso R; Vara Martín J
An Pediatr (Barc); 2010 May; 72(5):309-16. PubMed ID: 20347408
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive and renoprotective efficacy and safety of losartan. A long-term study in children with renal disorders.
Ellis D; Moritz ML; Vats A; Janosky JE
Am J Hypertens; 2004 Oct; 17(10):928-35. PubMed ID: 15485756
[TBL] [Abstract][Full Text] [Related]
7. [Hemolytic-uremic syndrome in Chile: clinical features, evolution and prognostic factors].
Zambrano O P; Delucchi B A; Cavagnaro S F; Hevia J P; Rosati M MP; Lagos R E; Nazal Ch V; González C C; Barrera B P; Alvarez L E; Pinto S V; Salas del C P; Cano Sch F; Contreras M A; Galanti de la P M; Gana A JC; Zamorano C J; Espinoza B A; Dreves R P; Pereira M J; Bidegain S A; Pasten P E; Yáñez P L; Cerda F V; Rodríguez S E; Aglony I M; Gutiérrez I E; Salas P F; Figueroa Y S; Valenzuela A M; Grandy H J; Guerra A B; Lapadula A M; Reutter de la M P; Gallardo T V; Maldonado S D; Azócar P M; Cavada Ch G
Rev Med Chil; 2008 Oct; 136(10):1240-6. PubMed ID: 19194619
[TBL] [Abstract][Full Text] [Related]
8. Long-term prognosis of hemolytic uremic syndrome and effective renal plasma flow.
Hüseman D; Gellermann J; Vollmer I; Ohde I; Devaux S; Ehrich JH; Filler G
Pediatr Nephrol; 1999 Oct; 13(8):672-7. PubMed ID: 10502125
[TBL] [Abstract][Full Text] [Related]
9. Clinical features, therapeutic interventions and long-term aspects of hemolytic-uremic syndrome in Norwegian children: a nationwide retrospective study from 1999-2008.
Jenssen GR; Vold L; Hovland E; Bangstad HJ; Nygård K; Bjerre A
BMC Infect Dis; 2016 Jun; 16():285. PubMed ID: 27297224
[TBL] [Abstract][Full Text] [Related]
10. [Changing clinical course of hemolytic uremic syndrome in children].
Zurowska A; Gockowska Z; Czarniak P; Marczak E
Pol Merkur Lekarski; 2000 Apr; 8(46):234-5. PubMed ID: 10897626
[TBL] [Abstract][Full Text] [Related]
11. Postdiarrheal Shiga toxin-mediated hemolytic uremic syndrome similar to septic shock.
Valles PG; Pesle S; Piovano L; Davila E; Peralta M; Principi I; Lo Giudice P
Medicina (B Aires); 2005; 65(5):395-401. PubMed ID: 16296634
[TBL] [Abstract][Full Text] [Related]
12. [Hemolytic uremic syndrome. Treatment of secondary glomerulopathy].
Caletti MG; Gallo G
Medicina (B Aires); 2005; 65(6):528-32. PubMed ID: 16433483
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of Czech children with D+ hemolytic-uremic syndrome.
Bláhová K; Janda J; Kreisinger J; Matejková E; Sedivá A
Pediatr Nephrol; 2002 Jun; 17(6):400-3. PubMed ID: 12107802
[TBL] [Abstract][Full Text] [Related]
14. Chronic renal failure in children.
Hari P; Singla IK; Mantan M; Kanitkar M; Batra B; Bagga A
Indian Pediatr; 2003 Nov; 40(11):1035-42. PubMed ID: 14660834
[TBL] [Abstract][Full Text] [Related]
15. Short-term and long-term outcome of hemolytic uremic syndrome in Iranian children.
Otukesh H; Hoseini R; Golnari P; Fereshtehnejad SM; Zamanfar D; Hooman N; Tabarroki A
J Nephrol; 2008; 21(5):694-703. PubMed ID: 18949724
[TBL] [Abstract][Full Text] [Related]
16. The natural history of renal function following orthotopic heart transplant.
Al Aly Z; Abbas S; Moore E; Diallo O; Hauptman PJ; Bastani B
Clin Transplant; 2005 Oct; 19(5):683-9. PubMed ID: 16146562
[TBL] [Abstract][Full Text] [Related]
17. [Hemolytic-uremic syndrome in children: a 19-year retrospective study].
Imoberdorf G; Bianchetti MG; Rossi E; Gugler E; Oetliker OH
Schweiz Med Wochenschr; 1993 Jul; 123(29):1439-44. PubMed ID: 8367702
[TBL] [Abstract][Full Text] [Related]
18. Renal functional reserve evolution in children with a previous episode of hemolytic uremic syndrome.
Dieguez S; Ayuso S; Brindo M; Osinde E; Cánepa C
Nephron Clin Pract; 2004; 97(3):c118-22. PubMed ID: 15292689
[TBL] [Abstract][Full Text] [Related]
19. Long-term outcome of diarrhea-associated hemolytic uremic syndrome is poorly related to markers of kidney injury at 1-year follow-up in a population-based cohort.
Monet-Didailler C; Godron-Dubrasquet A; Madden I; Delmas Y; Llanas B; Harambat J
Pediatr Nephrol; 2019 Apr; 34(4):657-662. PubMed ID: 30368614
[TBL] [Abstract][Full Text] [Related]
20. Hemolytic-uremic syndrome (HUS): a clinicopathological study of 15 cases.
Tinaztepe K; Akkök N; Tinaztepe B
Turk J Pediatr; 1993; 35(1):23-36. PubMed ID: 8236514
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
